The EU Joint Clinical Assessment (JCA) is transforming how pharmaceutical companies approach market access in Europe.
Join our upcoming Better Market Access webinar to explore the evolving EU JCA landscape and its far-reaching impact on pharmaceutical market access strategies. With perspectives from our EU JCA experts and insights from more than 10 pharmaceutical companies, this session will deliver timely updates and best practices.
This webinar will cover:
- The latest EU JCA updates, including which products are currently under assessment.
- Key lessons from progress made so far in the EU JCA process.
- How payers plan to integrate JCA reports into local pricing and reimbursement negotiations.
- Organizational changes companies have adopted to execute the EU JCA process
- Best practices and insights from companies navigating the preparation process.
This event is free of charge. Don't miss the opportunity to learn how different industry peers are preparing for the process.
Event details:
Tuesday, October 14 | 16:00 - 17:00 p.m. CET; 10:00 – 11:00 a.m. EST
